
Serena
Astaxanthin, two formats
Astaxanthin for skin, extracted with supercritical CO2 and offered in two formats: a dispersible powder and an oleoresin. Antioxidant capacity above vitamin E in vitro, target data.
Astaxanthin from Haematococcus pluvialis
Not for sale yet.
Still at the bench. Tell us what you would need it to do and we will come back when there is material worth sending you.
Request a sample →Ask for the proposed data sheetWhat it is being built for
- —Antioxidant and anti-pollution formats
- —Sensitive skin formats
- —Oil phase and dispersible systems
Proposed specification
| Status | In development, first lot targeted 2027 |
|---|---|
| Origin | Chile |
| INCI | Haematococcus Pluvialis Extract |
| Powder, target | 2% w/w astaxanthin |
| Oleoresin, target | 5% w/w astaxanthin |
| All-trans isomer | 40% min |
| Extraction | Supercritical CO2 |
| Use level | 0.2 to 2.0%, delivering 0.005 to 0.05% astaxanthin |
| Processing ceiling | Below 60 °C |
| Storage | 4 to 15 °C, dry and dark, cold chain |
| Packs | 1 / 5 kg |
Certificate of analysis is issued for the lot you receive, not a representative one.
Target performance
| Use level | 0.2 to 2.0%, delivering 0.005 to 0.05% astaxanthin |
|---|---|
| Processing ceiling | Below 60 °C |
| Storage | 4 to 15 °C, dry and dark. Cool chain. |
| Packaging | Airless and opaque. |
| Note | Different loading from Astera in the supplement line. Do not order across lines by name alone. |
Regulatory
| Status | Target specification. First lot targeted 2027. |
|---|
Documentation
- Proposed technical data sheet, under NDA
- Lab sample by signed letter of intent
Linked documents download now. Everything else ships with the order or the sample. Items marked in amber are released under a mutual non disclosure agreement. Ask and we send them the same day.
Put it in your matrix.
Samples ship in 5 business days with the certificate of analysis for the lot, so your team can check the numbers themselves.
